These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 10938476)
41. Adenosine receptor PET imaging in human brain. Mishina M; Ishiwata K Int Rev Neurobiol; 2014; 119():51-69. PubMed ID: 25175960 [TBL] [Abstract][Full Text] [Related]
42. In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experiments. Elmenhorst D; Kroll T; Wedekind F; Weisshaupt A; Beer S; Bauer A J Nucl Med; 2013 Aug; 54(8):1411-9. PubMed ID: 23740103 [TBL] [Abstract][Full Text] [Related]
43. Selective detection of adenosine A1 receptor-dependent G-protein activity in basal and stimulated conditions of rat brain [35S]guanosine 5'-(gamma-thio)triphosphate autoradiography. Laitinen JT Neuroscience; 1999; 90(4):1265-79. PubMed ID: 10338296 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist. Ishiwata K; Noguchi J; Toyama H; Sakiyama Y; Koike N; Ishii S; Oda K; Endo K; Suzuki F; Senda M Appl Radiat Isot; 1996; 47(5-6):507-11. PubMed ID: 8673072 [TBL] [Abstract][Full Text] [Related]
45. Reduced adenosine A1 receptor and G alpha protein coupling in rat ventricular myocardium during aging. Cai G; Wang HY; Gao E; Horwitz J; Snyder DL; Pelleg A; Roberts J; Friedman E Circ Res; 1997 Dec; 81(6):1065-71. PubMed ID: 9400388 [TBL] [Abstract][Full Text] [Related]
46. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor. Cohen FR; Lazareno S; Birdsall NJ Br J Pharmacol; 1996 Apr; 117(7):1521-9. PubMed ID: 8730749 [TBL] [Abstract][Full Text] [Related]
47. KW-3902, a selective high affinity antagonist for adenosine A1 receptors. Nonaka H; Ichimura M; Takeda M; Kanda T; Shimada J; Suzuki F; Kase H Br J Pharmacol; 1996 Apr; 117(8):1645-52. PubMed ID: 8732272 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain. Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808 [TBL] [Abstract][Full Text] [Related]
49. Maintenance of adenosine A1 receptor function during long-term anoxia in the turtle brain. Lutz PL; Manuel L Am J Physiol; 1999 Mar; 276(3):R633-6. PubMed ID: 10070121 [TBL] [Abstract][Full Text] [Related]
50. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists. Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591 [TBL] [Abstract][Full Text] [Related]
51. A1 adenosine receptors expressed in CHO-cells couple to adenylyl cyclase and to phospholipase C. Freund S; Ungerer M; Lohse MJ Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):49-56. PubMed ID: 7935854 [TBL] [Abstract][Full Text] [Related]
52. Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain. Concas A; Santoro G; Mascia MP; Maciocco E; Dazzi L; Ongini E; Biggio G J Pharmacol Exp Ther; 1993 Nov; 267(2):844-51. PubMed ID: 8246158 [TBL] [Abstract][Full Text] [Related]
53. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Alexander SP; Curtis AR; Kendall DA; Hill SJ Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists. Grahner B; Winiwarter S; Lanzner W; Müller CE J Med Chem; 1994 May; 37(10):1526-34. PubMed ID: 8182711 [TBL] [Abstract][Full Text] [Related]
55. Incorporation of [1-carbon-11]palmitate in monkey brain using PET. Arai T; Wakabayashi S; Channing MA; Dunn BB; Der MG; Bell JM; Herscovitch P; Eckelman WC; Rapoport SI; Chang MC J Nucl Med; 1995 Dec; 36(12):2261-7. PubMed ID: 8523117 [TBL] [Abstract][Full Text] [Related]
56. Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe. Kennedy AP; Mangum KC; Linden J; Wells JN Mol Pharmacol; 1996 Oct; 50(4):789-98. PubMed ID: 8863823 [TBL] [Abstract][Full Text] [Related]
57. 8-Azaxanthine derivatives as antagonists of adenosine receptors. Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944 [TBL] [Abstract][Full Text] [Related]
58. Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells. Hettinger-Smith BD; Leid M; Murray TF J Neurochem; 1996 Nov; 67(5):1921-30. PubMed ID: 8863496 [TBL] [Abstract][Full Text] [Related]
59. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development. Andrée B; Halldin C; Thorberg SO; Sandell J; Farde L Nucl Med Biol; 2000 Jul; 27(5):515-21. PubMed ID: 10962260 [TBL] [Abstract][Full Text] [Related]
60. Effects of substituent size upon adenosine receptor A1/A2 affinity of some newly synthesised 8-cycloalkyl xanthines. Castagnino E; Salvatori A; Corsano S; Tacchi P; Martini C; Lucacchini A Drug Des Discov; 1995 Apr; 12(4):313-21. PubMed ID: 9040991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]